Fibrato (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fibrato" in Galician language version.

Last modified: 15:14:25, 22 September 2026 (UTC)

Ref.Un. Ref.Website

Global rank Galician rank

55doi.org

2^nd place

3^rd place

44nih.gov

5^th place

2^nd place

11archive.org

6^th place

4^th place

11freepatentsonline.com

7,823^rd place

5,064^th place

11stacommunications.com

low place

11web.archive.org

1^st place

11impactaging.com

low place

archive.org (Global: 6^th place; Galician: 4^th place)

Wysocki J, Belowski D, Kalina M, Kochanski L, Okopien B, Kalina Z (2004). "Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome". International Journal of Clinical Pharmacology and Therapeutics 42 (4): 212–217. PMID 15124979. doi:10.5414/cpp42212.

doi.org (Global: 2^nd place; Galician: 3^rd place)

dx.doi.org

Steiner G (December 2007). "Atherosclerosis in type 2 diabetes: a role for fibrate therapy?". Diab Vasc Dis Res 4 (4): 368–74. PMID 18158710. doi:10.3132/dvdr.2007.067.
Abourbih S, Filion KB, Joseph L, Schiffrin EL, Rinfret S, Poirier P, Pilote L, Genest J, Eisenberg MJ (2009). "Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review". Am J Med 122 (10): 962.e1–962.e8. PMID 19698935. doi:10.1016/j.amjmed.2009.03.030.
Jun M, Foote C, Lv J, et al. (2010). "Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis". Lancet 375 (9729): 1875–1884. doi:10.1016/S0140-6736(10)60656-3.
Wysocki J, Belowski D, Kalina M, Kochanski L, Okopien B, Kalina Z (2004). "Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome". International Journal of Clinical Pharmacology and Therapeutics 42 (4): 212–217. PMID 15124979. doi:10.5414/cpp42212.
Zhao YY, Weir MA, Manno M, Cordy P, Gomes T, Hackam DG, et al. (2012). "New fibrate use and acute renal outcomes in elderly adults: a population-based study.". Ann Intern Med 156 (8): 560–9. PMID 22508733. doi:10.7326/0003-4819-156-8-201204170-00003.

freepatentsonline.com (Global: 7,823^rd place; Galician: 5,064^th place)

"Pharmaceutical composition and method for treatment of digestive disorders - Patent 4976970". Consultado o 2008-12-20.

impactaging.com (Global: low place; Galician: low place)

"Aging". www.impactaging.com. Arquivado dende o orixinal o 04 de marzo de 2016. Consultado o 13 April 2018.

nih.gov (Global: 5^th place; Galician: 2^nd place)

ncbi.nlm.nih.gov

Steiner G (December 2007). "Atherosclerosis in type 2 diabetes: a role for fibrate therapy?". Diab Vasc Dis Res 4 (4): 368–74. PMID 18158710. doi:10.3132/dvdr.2007.067.
Abourbih S, Filion KB, Joseph L, Schiffrin EL, Rinfret S, Poirier P, Pilote L, Genest J, Eisenberg MJ (2009). "Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review". Am J Med 122 (10): 962.e1–962.e8. PMID 19698935. doi:10.1016/j.amjmed.2009.03.030.
Wysocki J, Belowski D, Kalina M, Kochanski L, Okopien B, Kalina Z (2004). "Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome". International Journal of Clinical Pharmacology and Therapeutics 42 (4): 212–217. PMID 15124979. doi:10.5414/cpp42212.
Zhao YY, Weir MA, Manno M, Cordy P, Gomes T, Hackam DG, et al. (2012). "New fibrate use and acute renal outcomes in elderly adults: a population-based study.". Ann Intern Med 156 (8): 560–9. PMID 22508733. doi:10.7326/0003-4819-156-8-201204170-00003.

stacommunications.com (Global: low place; Galician: low place)

http://www.stacommunications.com/journals/cardiology/2004/June/Pdf/034.pdf

web.archive.org (Global: 1^st place; Galician: 1^st place)

"Aging". www.impactaging.com. Arquivado dende o orixinal o 04 de marzo de 2016. Consultado o 13 April 2018.

Fibrato (Galician Wikipedia)

archive.org (Global: 6th place; Galician: 4th place)

doi.org (Global: 2nd place; Galician: 3rd place)